Ketamine Toxicity

Overview

4.5 out of 5 (34 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Jan 2023

Last Review Date

30 Jan 2023

Expiration Date

31 Dec 2025

Estimated Time To Finish

60 Minutes

Start This Activity
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Ketamine is a structural analog of the dissociative anesthetic and recreational drug phencyclidine (PCP). Similar to phencyclidine, ketamine causes analgesia and amnesia without the cardiovascular and respiratory depression associated with common anesthetics. Originally called CI-581, ketamine has one-tenth the potency of PCP and causes less severe dysphoria and hallucinations. Intramuscular and intravenous forms of ketamine are commonly used to provide pediatric anesthesia, especially for high-risk children or patients in limited-resource settings. In surgical settings, ketamine is typically combined with benzodiazepines, which can reduce the adverse psychological symptoms that occur during emergence. Off-label, subanesthetic doses of ketamine also have a use for acute and chronic pain management, sedation, and treatment of severe depression. Like its chemical cousin phencyclidine, ketamine’s psychomimetic effects have made it a popular recreational drug. In low doses, its euphoric and dissociative effects are sometimes referred to as “k-land,” whereas at high doses, the immobilizing and hallucinogenic effects are referred to as being in a “k-hole.” In the context of an illegal, recreational drug, ketamine goes by the street names “K,” “vitamin K,” “super K,” “special K,” “super C,” “special LA coke,” “jet,” “superacid,” and “green.” Ketamine toxicity can cause a variety of neurological, cardiovascular, psychiatric, urogenital, and abdominal symptoms, which are dose-dependent, and whether ketamine administration was in an iatrogenic or illicit context. For example, some experts have attributed the higher incidence of ulcerative cystitis in recreational users to the adulterants with which the drug is mixed. Providers using ketamine should be aware of the various mechanisms to treat ketamine toxicity and to prevent acute complications such as rhabdomyolysis and seizures, and chronic complications such as psychiatric disturbances and ulcerative cystitis. This activity reviews the evaluation of ketamine toxicity and the role of the interprofessional team in managing this condition.

UAN: JA4008195-9999-23-353-H01-P

Target Audience

This activity has been designed to meet the educational needs of pharmacists.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Describe the chemical basis of ketamine.
  • Discuss the expected side effects of ketamine.
  • Explain the symptoms and signs of ketamine toxicity.
  • Outline medical team evaluation and management of a patient with ketamine toxicity.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. None of the planners of this educational activity have any relevant financial relationships to disclose.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Continuing Education Accreditation Information

Credit provided by Continuing Education, Inc, and StatPearls, LLC.

In support of improving patient care, this activity has been jointly planned and implemented by Continuing Education, Inc./University at Sea® and StatPearls, LLC. Continuing Education, Inc, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is designated for 1.00 contact hours for pharmacists.

FL Board of Pharmacy Tripartite, approval #20-608156.

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content in the activity.
  4. Choose the best answer to each activity test question. To receive credit, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment.
  6. Obtain a certificate.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Disclaimer

Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearlsand and Continuing Education, Inc, reserve the right to cancel any course due to unforeseen circumstances. StatPearls and Continuing Education, Inc, will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Medium or Media Used:

  • Computer Requirements: Internet Access
  • E-mail Address

Equal Opportunity

  • StatPearls and Continuing Education are Equal Opportunity/Affirmative Action/Equal Access Institutions. 

 

 
 

Reviews

Bhupendra M. on 5/8/2021

Sarah B. on 6/19/2021

Barbara C. on 8/20/2021

Mark M. on 9/13/2021

lee a. on 10/9/2021

Dr C. on 11/15/2021

MIA G. on 12/6/2021

Rene G. on 12/28/2021

Aaron B. on 2/22/2022

SANTHA A. on 3/2/2022

marina h. on 3/12/2022

Regina B. on 4/3/2022

Ehsan Q. on 4/26/2022

Rodabeh M. on 6/4/2022

Dawn P. on 6/8/2022

None

Leonor P. on 7/3/2022

Spencer a. on 9/19/2022

Ashley H. on 9/20/2022

Eli N. on 10/5/2022

Susan A. on 10/12/2022

Richard S. on 10/12/2022

Chelsea H. on 10/22/2022

jeffrey t. on 11/3/2022

Douglas M. on 12/15/2022

Marc D. on 1/12/2023

Jeffrey H. on 2/1/2023

Lynn J. on 3/8/2023

Kathryn P. on 4/29/2023

coral c. on 5/4/2023

Mary Y. on 5/21/2023

Brian F. on 6/9/2023

Kimberley R. on 6/12/2023

Elizabeth M. on 6/14/2023

Monica H. on 8/5/2023

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 3469 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 4234.5 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user